cid:image001.jpg@01C91F09.9CE35280Ary Sarkar, Founder, Chairman & CEO
Arable Corporation

Mr. Sarkar brings to Arable Corporation 17+ years of sales and entrepreneurial experience in identifying and capitalizing upon strategic market opportunities. He adds depth to the senior management team and brings a general management perspective to help enable Arable execute its global expansion strategy.  With his vast experience in pharmaceutical industry, he is pivotal to Arable Corporation’s growth plans in the Global Clinical and Regulatory space for CTMS & EDC solutions. Before founding Arable Corporation, he was Vice President Global Strategy and Alliances at Octagon Research Solutions, Inc., a leading provider of software and services to optimize the clinical R&D process in the Bio pharmaceutical industry from data collection to submission Prior to that he was Vice President Corporate Development at Ninaza, a pioneer in web-based Electronic Data Capture (EDC) technology, working with Contract Research Organizations (CROs) specializing in health outcomes research. Ninaza was acquired by Octagon Research Solutions, Inc. Mr. Sarkar graduated from the prestigious Mayo College, Ajmer, called the "Eton of India" and St. Stephen's College, Delhi University in Delhi. He also completed his MBA from Modern Institute of Management in New Delhi.


Dr. Subodh Bhardwaj, Vice President Research and Development
Arable Corporation

Dr. Bhardwaj joined Arable from Sanofi-Aventis were he successfully researched and launched several products including IVF range (Ares-Serono) and the full range of pediatric, adult and travel vaccine. He was the first to license Panenza (A H1N1) pandemic vaccine and supplied to MoH&P, Govt. of India in 2010. First to launch the only IPV based, Acellular containing (DTP-Hib-IPV) pentavalent vaccine, PENTAXIM in India. He is an avid researcher with more than 60 publications in National and International journals. He is associated with research of new indigenous and affordable rabies vaccines and monoclonal antibodies with MNCs like Acambis, Crucell and MBL. Expert in Pharmaco-vigilance and new drugs development. Dr. Bhardwaj will be leading the R&D team at Arable with his strong leadership, management and organizational skills. Has been associated with large clinical trials on MMR vaccine in Egypt, clinical research in Russia, Ukraine, Turkey and Chile. Associated with research of new indigenous and affordable rabies vaccines and monoclonal antibodies with MNCs like Acambis, Crucell and MBL. Expert in Pharmaco-vigilance and new drugs development. He completed MBBS from Govt. Medical College, J&K India and MD (Clinical Pharmacology) from J.N. Medical College, AMU, Aligarh is a physician with 30 years experience in the field of Medicine. He has worked with Sanofi-Aventis and Serum Institute of India Ltd., Pune and has about two decades of experience with pharmaceutical products, vaccines and biologicals.




Bruce D. Schatzman :: CEO and FounderRahul Mistry, CEO Global Submit
(Arable Partner)

Mr. Mistry is a software industry veteran with over a decade of experience developing and deploying cutting edge software solutions. He has worked extensively with some of the largest pharmaceutical companies in the world and developed eCTD review and validate software for FDA use. Throughout his tenure he has led GlobalSubmit to its current position as a market leader in the development and delivery of solutions that support Regulated Product Submissions (RPS) and the eCTD. Rahul holds a bachelor’s degree from Princeton University.

 


Jeffrey K. West :: Manager, Professional ServicesDr. Amit Sarkar, Chief Legal Advisor
Arable Corporation

Dr. Amit Sarkar, Ph. D., LL. B. retired as Judge in India and thereafter served as Senior Attorney Supreme Court of India. He practiced corporate and International law at Supreme Court of India and was legal counsel to several Multinational Corporations. As a Corporate Attorney, he contributed to growth of many Joint Ventures and Indo-American Collaborations. While Judicial Secretary to Centrally administered Government of Mizoram, India, his draft amendment to Sixth Schedule to the Constitution of India was concurred by the Union Government and legislated by the Indian Parliament. He authored several books on law-allied subjects. He was also a Specialist teacher at the National Institute of Criminology and Forensic Science. He was a visiting scholar to Boston University. He studied US Criminal Law and Criminal Justice Administration in Northeastern University at Boston. Dr. Sarkar is a Life Member of Indian Association of Criminology and South Asian Bar Association of Greater Boston, USA.

back to top

Arable Corp
sdaf
d
For Sponsors
ds
For CROs dsf
fdg
For Collaborative Teams ddsg
fg
Global Deployment xdfg
vfbg
Regulatory Compliance gh
fgh
Scalable Technology & Pricing gh
fgh

For More Information
Please fill out form below.

Name:
Email:
Company Name:
Phone Number:
Message:



For Sales Information
Email: sales@arablecorp.com
spacer
or Call: 650.331.1401